BouthainaShbibDabajaMD

Radiation Oncology • Houston, TX

Physician

Join to view full profile

Dr. Dabaja is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dabaja's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Education & Training

University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1999 - 2003
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1997 - 1999
Lebanese University School of MedicineClass of 1991

Certifications & Licensure

FL State Medical License 2021 - Present
AZ State Medical License 2022 - 2026
GA State Medical License 2022 - 2026
TN State Medical License 2022 - 2026
AL State Medical License 2022 - 2025
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025
OK State Medical License 2020 - 2025
TX State Medical License 2006 - 2025
WA State Medical License 2022 - 2025
American Board of Radiology Radiation Oncology
Join now to see all

Clinical Trials

Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy Start of enrollment: 2009 Jun 01
Terminated
Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides Start of enrollment: 2010 Feb 01
Completed
Phase 2
Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides Start of enrollment: 2010 Dec 01
Terminated
Phase 1, Phase 2
Stage I/II Nasal NK Cell Lymphoma Start of enrollment: 2011 May 01
Terminated
Phase 1, Phase 2
Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma Start of enrollment: 2013 May 20
Recruiting
Phase 1, Phase 2
Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma Start of enrollment: 2015 Jan 16
Recruiting
Phase 2
Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides Start of enrollment: 2018 Jan 06
Recruiting
Phase 2
Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma Start of enrollment: 2019 Jun 14
Recruiting
Phase 2
Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Start of enrollment: 2000 Jun 07
Completed
Phase 2
Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors Start of enrollment: 2021 Jun 30
Recruiting
Early Phase 1
Roles: Principal Investigator, Contact
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides Start of enrollment: 2022 Oct 13
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

On the Way to Curing Advanced-Stage Mycosis Fungoides/Sézary Syndrome.
Seda Purnak, Chitra Hosing, Bouthaina Dabaja, Roland L Bassett, Auris Huen
Clinical Lymphoma, Myeloma & Leukemia. 2024-12-01
Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung.
Susan Y Wu, Penny Q Fang, Ahmed Fetooh, Gohar S Manzar, Kelsey L Corrigan
Advances in Radiation Oncology. 2024-12-01
Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?
Penny Fang, Sonal S Noticewala, Susan Y Wu, Jillian R Gunther, Ethan B Ludmir
Advances in Radiation Oncology. 2024-12-01

Journal Articles

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients with Early-Stage Favorable Hodgkin Lymphoma Treated with Contemporary Radiation Therapy
Chelsea C Pinnix, Jillian R Gunther, Sarah A Milgrom, Jason Westin, Simrit Parmar, Loretta Nastoupil, Sattva Neelapu, Bouthaina S Dabaja, JAMA Network Open

Abstracts/Posters

Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell LymphomaRadiation Therapy Can be ...
Bouthaina S. Dabaja, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Low-Dose Radiation Effective With/Without Concurrent Chemotherapy in R/R Mantle Cell LymphomaSeptember 5th, 2019
Guidelines for Proton Therapy in Mediastinal LymphomasSeptember 19th, 2018
Family First After My Non-Hodgkin’s B-cell Lymphoma DiagnosisJanuary 17th, 2017